Shield Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Shield Therapeutics has a total shareholder equity of $27.1M and total debt of $5.7M, which brings its debt-to-equity ratio to 21.1%. Its total assets and total liabilities are $41.7M and $14.6M respectively.
Key information
21.1%
Debt to equity ratio
US$5.71m
Debt
| Interest coverage ratio | n/a |
| Cash | US$13.59m |
| Equity | US$27.10m |
| Total liabilities | US$14.57m |
| Total assets | US$41.67m |
Recent financial health updates
Here's Why We're Watching Shield Therapeutics' (LON:STX) Cash Burn Situation
Mar 02
We're Interested To See How Shield Therapeutics (LON:STX) Uses Its Cash Hoard To Grow
Jan 27
Recent updates
Here's Why We're Watching Shield Therapeutics' (LON:STX) Cash Burn Situation
Mar 02What Does The Future Hold For Shield Therapeutics plc (LON:STX)? These Analysts Have Been Cutting Their Estimates
May 06Shield Therapeutics (LON:STX) Shareholders Have Enjoyed An Impressive 111% Share Price Gain
Mar 15We're Interested To See How Shield Therapeutics (LON:STX) Uses Its Cash Hoard To Grow
Jan 27Trade Alert: The CEO & Director Of Shield Therapeutics plc (LON:STX), Timothy Watts, Has Just Spent UK£70k Buying 22% More Shares
Dec 15Financial Position Analysis
Short Term Liabilities: STX's short term assets ($26.1M) exceed its short term liabilities ($8.9M).
Long Term Liabilities: STX's short term assets ($26.1M) exceed its long term liabilities ($5.7M).
Debt to Equity History and Analysis
Debt Level: STX has more cash than its total debt.
Reducing Debt: STX's debt to equity ratio has increased from 0% to 21.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if STX has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if STX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.